LGALS4 and pancreatic adenocarcinoma: Gal-4 expression is not detected in healthy pancreas, but is significantly enhanced in cystic tumors of the human pancreas and pancreatic adenocarcinomas compared to normal tissue samples, whereas its expression is low in pancreatic neuroendocrine tumors [26], [27], [29], [30], [31].